|
2025 Journal Article ZRSR2 loss causes aberrant splicing in JAK2V617F‐driven myeloproliferative neoplasm but is not sufficient to drive disease progressionZhang, Ranran, Straube, Jasmin, Janardhanan, Yashaswini, Haldar, Rohit, Cooper, Leanne, Hayes, Noah, Laurore, Charles, Kim, Chulwoo J., Luskin, Marlise R., Lindsley, Robert C., Stahl, Maximilian, Mullally, Ann, Marneth, Anna E., Bywater, Megan and Lane, Steven W. (2025). ZRSR2 loss causes aberrant splicing in JAK2V617F‐driven myeloproliferative neoplasm but is not sufficient to drive disease progression. HemaSphere, 9 (9) e70225, 1-6. doi: 10.1002/hem3.70225 |
|
2024 Conference Publication 3035 – INTERFERON ALPHA THERAPY ATTENUATES LEUKAEMIC TRANSFORMATION IN JAK2V617F-DRIVEN MPN WITH TRP53-LOSSBywater, Megan, Zhang, Ranran, Grabek, Julian, Halder, Rohit, Janardhanan, Yashaswini, Cooper, Leanne, Cooper, Emily, Ross, David, Straube, Jasmin and Lane, Steven (2024). 3035 – INTERFERON ALPHA THERAPY ATTENUATES LEUKAEMIC TRANSFORMATION IN JAK2V617F-DRIVEN MPN WITH TRP53-LOSS. EXPHEM 2024, Philadelphia, PA, United States: Elsevier BV. doi: 10.1016/j.exphem.2024.104357 |
|
2024 Other Outputs CRISPR-Cas9 approaches to model Myeloproliferative Neoplasms in vivoZhang, Ranran (2024). CRISPR-Cas9 approaches to model Myeloproliferative Neoplasms in vivo. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/0e84c4b |
|
2023 Conference Publication Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse ModelZhang, Ranran, Janardhanan, Yashaswini, Haldar, Rohit, Cooper, Leanne, Jaquelin, Sebastien, Straube, Jasmin, Bywater, Megan and Lane, Steven W. (2023). Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse Model. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-188150 |
|
2021 Journal Article Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemiaLi, Yizhen, Yang, Wentao, Devidas, Meenakshi, Winter, Stuart S., Kesserwan, Chimene, Yang, Wenjian, Dunsmore, Kimberly P., Smith, Colton, Qian, Maoxiang, Zhao, Xujie, Zhang, Ranran, Gastier-Foster, Julie M., Raetz, Elizabeth A., Carroll, William L., Li, Chunliang, Liu, Paul P., Rabin, Karen R., Sanda, Takaomi, Mullighan, Charles G., Nichols, Kim E., Evans, William E., Pui, Ching-Hon, Hunger, Stephen P., Teachey, David T., Relling, Mary, Loh, Mignon L. and Yang, Jun J. (2021). Germline RUNX1 variation and predisposition to childhood acute lymphoblastic leukemia. Journal of Clinical Investigation, 131 (17) e147898, 1-14. doi: 10.1172/jci147898 |
|
2020 Journal Article 4-hydroxyphenyl retinamide preferentially targets FLT3 mutated acute myeloid leukemia via ROS induction and NF-kappa B inhibitionZhao, Xin-ying, Zhang, Ran-ran, Ye, Qian, Qiu, Fei, Xu, Hao-yu, Wei, Feng-gui and Zhang, Hui (2020). 4-hydroxyphenyl retinamide preferentially targets FLT3 mutated acute myeloid leukemia via ROS induction and NF-kappa B inhibition. Current Medical Science, 40 (5), 810-816. doi: 10.1007/s11596-020-2259-0 |
|
2020 Journal Article Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cellsZhang, Hui, Xu, Haoyu, Zhang, Ranran, Zhao, Xinying, Liang, Ming and Wei, Fenggui (2020). Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells. Cancer Chemotherapy and Pharmacology, 86 (2), 257-266. doi: 10.1007/s00280-020-04115-y |
|
2019 Conference Publication Germline RUNX1 variation and predisposition to T-cell acute lymphoblastic leukemia in childrenLi, Yizhen, Qian, Maoxiang, Devidas, Meenakshi, Yang, Wentao, Winter, Stuart S., Dunsmore, Kimberly P., Smith, Colton A., Lin, Ting-Nien, Zhao, Xuijie, Zhang, Ranran, Foster, Julie M. Gastier, Raetz, Elizabeth A., Carroll, William L., Rabin, Karen R., Yang, Wenjian, Zweidler-McKay, Patrick A., Pui, Ching-Hon, Evans, William E., Mullighan, Charles G., Hunger, Stephen P., Relling, Mary V., Loh, Mignon L. and Yang, Jun J. (2019). Germline RUNX1 variation and predisposition to T-cell acute lymphoblastic leukemia in children. 61st Annual Meeting of the American-Society-of-Hematology (ASH), Orlando, FL, United States, 7-10 December 2019. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2019-125912 |
|
2018 Journal Article Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemiaChurchman, Michelle L., Qian, Maoxiang, te Kronnie, Geertruy, Zhang, Ranran, Yang, Wenjian, Zhang, Hui, Lana, Tobia, Tedrick, Paige, Baskin, Rebekah, Verbist, Katherine, Peters, Jennifer L., Devidas, Meenakshi, Larsen, Eric, Moore, Ian M., Gu, Zhaohui, Qu, Chunxu, Yoshihara, Hiroki, Porter, Shaina N., Pruett-Miller, Shondra M., Wu, Gang, Raetz, Elizabeth, Martin, Paul L., Bowman, W. Paul, Winick, Naomi, Mardis, Elaine, Fulton, Robert, Stanulla, Martin, Evans, William E., Relling, Mary V. ... Mullighan, Charles G. (2018). Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia. Cancer Cell, 33 (5), 937-948. doi: 10.1016/j.ccell.2018.03.021 |
|
2017 Journal Article Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBPQian, Maoxiang, Zhang, Hui, Kham, Shirley Kow-Yin, Liu, Shuguang, Jiang, Chuang, Zhao, Xujie, Lu, Yi, Goodings, Charnise, Lin, Ting-Nien, Zhang, Ranran, Moriyama, Takaya, Yin, Zhaohong, Li, Zhenhua, Quah, Thuan Chong, Ariffin, Hany, Tan, Ah Moy, Shen, Shuhong, Bhojwani, Deepa, Hu, Shaoyan, Chen, Suning, Zheng, Huyong, Pui, Ching-Hon, Yeoh, Allen Eng-Juh and Yang, Jun J. (2017). Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP. Genome Research, 27 (2), 185-195. doi: 10.1101/gr.209163.116 |
|
2016 Conference Publication Whole transcriptome sequencing identified a distinct subtype of acute lymphoblastic leukemia with abnormalities of CREBBP and EP300Zhang, Hui, Qian, Maoxiang, Shirley,, Kham, Kow Yin, Liu, Shuguang, Jiang, Chuang, Zhao, Xujie, Lu, Yi, Lin, Ting-Nien, Zhang, Ranran, Moriyama, Takaya, Yin, Zhaohong, Shi, Lei, Li, Zhenhua, Chiew, Kean-Hui, Chen, Zhiwei, Deepa, Bhojwani, Shen, Shuhong, Zheng, Huyong, Pui, Ching-Hon, Yeoh, Allen Eng Juh and Yang, Jun J. (2016). Whole transcriptome sequencing identified a distinct subtype of acute lymphoblastic leukemia with abnormalities of CREBBP and EP300. 58th Annual Meeting and Exposition of the American Society of Hematology (ASH), San Diego, CA, United States, 3-6 December 2016. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood.v128.22.3912.3912 |
|
2016 Conference Publication Germline genetic variation in IKZF1 and predisposition to childhood acute lymphoblastic leukemiaChurchman, Michelle L., Qian, Maoxiang, Zhang, Ranran, Kronnie, Geertruy, Yang, Wenjian, Zhang, Hui, Lana, Tobia, Tedrick, Paige, Baskin, Rebekah, Verbist, Katherine, Devidas, Meenakshi, Raetz, Elizabeth, Larsen, Eric, Martin, Paul L., Bowman, W. Paul, Winick, Naomi, Mardis, Elaine R, Fulton, Robert S., Stanulla, Martin, Evans, William E., Relling, Mary V., Pui, Ching-Hon, Handgretinger, Rupert, Hunger, Stephen P., Loh, Mignon L., Nichols, Kim E., Mullighan, Charles and Yang, Jun J. (2016). Germline genetic variation in IKZF1 and predisposition to childhood acute lymphoblastic leukemia. 58th ASH Annual Meeting, San Diego, CA, United States, 3-6 December 2016. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood.v128.22.lba-2.lba-2 |
|
2016 Conference Publication Chemosensitizing effect of Fenretinide-induced NF-κb inhibition in AML therapyZhang, Ranran, Fenggui, Wei, Chen, Ru, Liang, Ming, Wu, Liping, Zhang, Hui and Chen, Fuxiong (2016). Chemosensitizing effect of Fenretinide-induced NF-κb inhibition in AML therapy. 58th ASH Annual Meeting, San Diego, CA United States, 3-6 December 2016. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v128.22.1580.1580 |
|
2015 Journal Article Research progress on chemoresistance mechanism of nuclear factor kappa B signalling patheway in acute myeloid leukemiaZhang, Ran-Ran, Zhang, Hui and Chen, Fu-Xiong (2015). Research progress on chemoresistance mechanism of nuclear factor kappa B signalling patheway in acute myeloid leukemia. Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology, 23 (6), 1785-1790. doi: 10.7534/j.issn.1009-2137.2015.06.046 |
